Skip to content

Double and Single Intrauterine Insemination In Controlled Ovarian Stimulation (COH) Cycles With Multifollicular Development

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00993902
Enrollment
228
Registered
2009-10-14
Start date
2008-05-31
Completion date
2009-07-31
Last updated
2009-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Double IUI, Intrauterine insemination, Unexplained infertility

Brief summary

Our hypothesis is double insemination will improve pregnancy rates in coh cycles with more than one dominant follicles (\>16mm).

Detailed description

Metaanalysis for the effects of double IUI demonstrates that effects of this procedure is not different from single IUI. It is known that nearly 25% of coh cycles is evident by monofollicular development.For this reason it is possible that this monofollicular cycles in the studies could decrease the effects of double IUI. Inclusion criteria: 1. Patients with unexplained infertility or mild male factor infertility whom admitted to the COH+IUI programme in our infertility unit. 2. Female age \<37 years old. 3. Baseline FSH \<12 mIU/L 4. Total antral follicle count\>6 5. During the first three cycles of COH+IUI 6. Minimum 2 follicles \>16 mm at the day of HCG. Primary outcome: Ongoing pregnancy rates Secondary outcomes: The effects of different coh regimens (CC,FSH,CC+FSH)on the outcomes.

Interventions

PROCEDUREIntrauterine insemination (single)

Single IUI after 36-38 hours of HCG

PROCEDUREDouble intrauterine insemination

Double insemination after 18 and 40 hours of HCG administration.

Sponsors

Baskent University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 37 Years
Healthy volunteers
Yes

Inclusion criteria

* Unexplained and mild male factor infertile patients * Minimum 2 follicles \>16 mm at the day of HCG * First 3 cycles

Exclusion criteria

* Basal FSH \>12 mIU/L * Total antral follicle count\<6 * Severe male factor infertility

Design outcomes

Primary

MeasureTime frame
ongoing pregnancy ratespregnancy >12 weeks of gestation

Secondary

MeasureTime frame
The effects of different coh regimens on outcomes14 days after IUI procedure

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026